Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02664831 · ClinicalTrials.gov registry record

Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)

A clinical trial of Obesity and Inflammation, sponsored by MaineHealth.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT02664831: Recruiting study of Obesity and Inflammation, sponsored by MaineHealth.

NCT02664831 is a study of Obesity and Inflammation that is actively recruiting participants, run by MaineHealth. The registered enrollment target is 400 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02664831, a study of Obesity and Inflammation, is actively recruiting participants, sponsored by MaineHealth.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

This is a prospective, observational study to investigate molecular mechanisms mediating the systemic inflammatory process, and changes to metabolism, and their impact on brain injury, survival, and functional outcomes after cardiac arrest. Investigators have shown that cardiac arrest induces changes in the numbers and properties of circulating immune cells, shifting the balance towards a pro-inflammatory phenotype and there is increased interest in the inflammatory pathways and the signaling mechanisms through which they are modulated. Participants will undergo blood sampling during 7 days following cardiac arrest, and analyses performed. Patient characteristics, clinical circumstances, and outcomes will be recorded and their associations with these inflammatory pathways characterized.

Primary Outcome

Correlations between inflammatory markers and clinical outcomes

Study Locations (1)

Maine

  • Maine Medical Center - Portland

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2016-01
Est. Completion 2028-01
MaineHealth

26 total trials

What NCT02664831 shows while recruiting

NCT02664831 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (51% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT02664831 reports a single indexed study location in Maine.

Frequently Asked Questions

What is clinical trial NCT02664831 about?

NCT02664831 is a clinical study titled "Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)". This is a prospective, observational study to investigate molecular mechanisms mediating the systemic inflammatory process, and changes to metabolism, and their impact on brain injury, survival, and functional outcomes after cardiac arrest. Investigators have shown that cardiac arrest induces change...

What is the current status of trial NCT02664831?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2016-01. Estimated completion is 2028-01.

What conditions does trial NCT02664831 study?

This clinical trial studies the following conditions: Obesity, Inflammation, Cardiac Arrest, Hypoxic Ischemic Encephalopathy (HIE).

Who is sponsoring clinical trial NCT02664831?

This trial is sponsored by MaineHealth, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02664831 being conducted?

This trial has 1 study location across Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02664831's enrollment target sits among peer trials

400 170th of 1053 higher than 881 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02664831, the US trial registry maintained by the National Library of Medicine. NCT02664831 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.